ALX Oncology (ALXO) Insider Trading & Ownership $1.41 +0.12 (+9.30%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALX Oncology (NASDAQ:ALXO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$152,124.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.85 M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALXO Insider Buying and Selling by Quarter Ad Brownstone ResearchMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. ALX Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Shelly PintoCAOSell564$2.58$1,455.12 8/14/2024Sophia RandolphInsiderSell1,365$2.58$3,521.70 7/11/2024Jaume PonsInsiderSell20,000$7.90$158,000.00 7/5/2024Shelly PintoCAOSell1,823$5.50$10,026.50 7/1/2024Shelly PintoCAOSell1,373$5.82$7,990.86 7/1/2024Sophia RandolphInsiderSell3,273$5.82$19,048.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/13/2024Peter S GarciaCFOBuy12,000$8.53$102,360.00 6/4/2024Jaume PonsInsiderSell20,000$8.43$168,600.00 5/13/2024Sophia RandolphInsiderSell12,000$15.94$191,280.00 5/6/2024Jaume PonsInsiderSell20,000$15.92$318,400.00 4/16/2024Jaume PonsInsiderSell50,000$14.20$710,000.00 4/4/2024Jaume PonsInsiderSell20,000$11.15$223,000.00 3/14/2024Jason LettmannCEOBuy4,400$11.31$49,764.00 1/4/2024Shelly PintoCAOSell2,717$13.60$36,951.20 (Data available from 1/1/2013 forward) ALXO Insider Trading Activity - Frequently Asked Questions Who is on ALX Oncology's Insider Roster? The list of insiders at ALX Oncology includes Jason Lettmann, Jaume Pons, Lsv Associates, Llc, Peter S Garcia, Shelly Pinto, and Sophia Randolph. Learn more on insiders at ALXO. What percentage of ALX Oncology stock is owned by insiders? 33.40% of ALX Oncology stock is owned by insiders. Learn more on ALXO's insider holdings. Which ALX Oncology insiders have been buying company stock? The following insiders have purchased ALXO shares in the last 24 months: Jason Lettmann ($49,764.00), and Peter S Garcia ($102,360.00). How much insider buying is happening at ALX Oncology? Insiders have purchased a total of 16,400 ALXO shares in the last 24 months for a total of $152,124.00 bought. Which ALX Oncology insiders have been selling company stock? The following insiders have sold ALXO shares in the last 24 months: Jaume Pons ($1,601,546.72), Peter S Garcia ($6,510.58), Shelly Pinto ($107,733.52), and Sophia Randolph ($225,631.26). How much insider selling is happening at ALX Oncology? Insiders have sold a total of 166,626 ALX Oncology shares in the last 24 months for a total of $1,941,422.08 sold. ALX Oncology Key ExecutivesDr. Corey S. Goodman Ph.D. (Age 72)Executive Chairman Compensation: $84kMr. Jason W. Lettmann (Age 47)CEO & Director Compensation: $60.5kDr. Jaume Pons Ph.D. (Age 57)Founder, President, Director & Chief Scientific Officer Compensation: $856.29kMr. Peter S. Garcia M.B.A. (Age 62)Chief Financial Officer Compensation: $631.11k1 recent tradesDr. Sophia Randolph M.D. (Age 56)Ph.D., Chief Medical Officer & Director Compensation: $637.24kDr. Michael Chang Ph.D.Vice President of OperationsMs. Shelly Pinto (Age 47)Senior VP of Finance & Chief Accounting Officer Compensation: $508.26k3 recent tradesDr. Christopher Byrd J.D.Ph.D., General CounselDr. Athanasios Tsiatis M.D.Senior Vice President of Clinical DevelopmentDr. Lin Yeong-Liang M.D.M.S., Senior Vice President of Drug Safety & Pharmacovigilance More Insider Trading Tools from MarketBeat Related Companies Poseida Therapeutics Insider Buying Lifecore Biomedical Insider Buying Lyell Immunopharma Insider Buying Atai Life Sciences Insider Buying Atyr PHARMA Insider Buying Mersana Therapeutics Insider Buying Fate Therapeutics Insider Buying Benitec Biopharma Insider Buying Biomea Fusion Insider Buying Zentalis Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ALXO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
